APPLICATION OF MULTI-CRITERIA DECISION ANALYSIS (MCDA) SCORING AS AN HTA METHODOLOGY FOR OFF-PATENT PHARMACEUTICALS (OPP) IN EMERGING MARKETS
View/ Open
Published version
Embargoed until: 5555-01-01
Reason: Version Not Permitted
Embargoed until: 5555-01-01
Reason: Version Not Permitted
Volume
19
Number of pieces
A815 - A815
DOI
10.1016/j.jval.2016.08.663
Journal
VALUE IN HEALTH
Issue
ISSN
1098-3015